MeiraGTx Holdings Plc (MGTX)
13.25
+0.20
(+1.53%)
USD |
NASDAQ |
Sep 18, 16:00
13.25
0.00 (0.00%)
Pre-Market: 20:00
MeiraGTx Holdings Cash from Investing (Quarterly) : -23.63M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.63M |
| March 31, 2026 | -2.258M |
| December 31, 2025 | -1.089M |
| September 30, 2025 | -0.547M |
| June 30, 2025 | -0.761M |
| March 31, 2025 | -1.71M |
| December 31, 2024 | -1.218M |
| September 30, 2024 | -1.314M |
| June 30, 2024 | -1.329M |
| March 31, 2024 | 27.34M |
| December 31, 2023 | 51.18M |
| September 30, 2023 | -3.564M |
| June 30, 2023 | -4.975M |
| March 31, 2023 | -8.605M |
| December 31, 2022 | |
| September 30, 2022 | -10.01M |
| June 30, 2022 | -14.00M |
| March 31, 2022 | -12.46M |
| December 31, 2021 | -25.37M |
| Date | Value |
|---|---|
| September 30, 2021 | -11.90M |
| June 30, 2021 | -5.575M |
| March 31, 2021 | -18.87M |
| December 31, 2020 | -10.23M |
| September 30, 2020 | -19.83M |
| June 30, 2020 | -2.916M |
| March 31, 2020 | -4.036M |
| December 31, 2019 | -5.139M |
| September 30, 2019 | -2.024M |
| June 30, 2019 | -1.092M |
| March 31, 2019 | -1.115M |
| December 31, 2018 | -8.886M |
| September 30, 2018 | -1.055M |
| June 30, 2018 | -0.1076M |
| March 31, 2018 | -1.210M |
| December 31, 2017 | |
| September 30, 2017 | -6.065M |
| June 30, 2017 | -0.587M |
| March 31, 2017 | -1.738M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Xencor, Inc. | 85.12M |
| UroGen Pharma Ltd. | 1.185M |
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Viking Therapeutics, Inc. | 109.43M |
| IDEAYA Biosciences, Inc. | -155.93M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -38.54M |
| Cash from Financing (Quarterly) | 133.89M |
| Free Cash Flow | 10.06M |
| Free Cash Flow Per Share (Quarterly) | -0.4144 |
| Free Cash Flow to Equity (Quarterly) | -63.66M |
| Free Cash Flow to Firm (Quarterly) | -35.41M |
| Free Cash Flow Yield | 0.90% |